WO2005067738A1 - グリシンを含有する食品およびその用途 - Google Patents
グリシンを含有する食品およびその用途 Download PDFInfo
- Publication number
- WO2005067738A1 WO2005067738A1 PCT/JP2004/019771 JP2004019771W WO2005067738A1 WO 2005067738 A1 WO2005067738 A1 WO 2005067738A1 JP 2004019771 W JP2004019771 W JP 2004019771W WO 2005067738 A1 WO2005067738 A1 WO 2005067738A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycine
- food
- hydrolysis
- substance
- converted
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title claims abstract description 375
- 239000004471 Glycine Substances 0.000 title claims abstract description 187
- 235000013305 food Nutrition 0.000 title claims abstract description 146
- 239000000126 substance Substances 0.000 claims abstract description 52
- 208000019116 sleep disease Diseases 0.000 claims abstract description 24
- 235000012054 meals Nutrition 0.000 claims abstract description 17
- 208000020685 sleep-wake disease Diseases 0.000 claims abstract description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 52
- 230000007062 hydrolysis Effects 0.000 claims description 48
- 150000001413 amino acids Chemical class 0.000 claims description 32
- 230000000873 masking effect Effects 0.000 claims description 15
- 235000009508 confectionery Nutrition 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 235000015110 jellies Nutrition 0.000 claims description 7
- 239000008274 jelly Substances 0.000 claims description 6
- 239000002002 slurry Substances 0.000 claims description 6
- 230000006872 improvement Effects 0.000 claims description 5
- 235000011962 puddings Nutrition 0.000 claims description 5
- 235000013618 yogurt Nutrition 0.000 claims description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 4
- 206010022437 insomnia Diseases 0.000 claims description 4
- 206010012735 Diarrhoea Diseases 0.000 claims description 2
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 abstract description 10
- 235000019634 flavors Nutrition 0.000 abstract description 10
- 230000007958 sleep Effects 0.000 description 84
- 230000000694 effects Effects 0.000 description 32
- 206010041349 Somnolence Diseases 0.000 description 13
- 230000037406 food intake Effects 0.000 description 12
- 230000002618 waking effect Effects 0.000 description 12
- 206010016256 fatigue Diseases 0.000 description 10
- 208000032140 Sleepiness Diseases 0.000 description 8
- 230000003340 mental effect Effects 0.000 description 8
- 229940068196 placebo Drugs 0.000 description 8
- 239000000902 placebo Substances 0.000 description 8
- 230000037321 sleepiness Effects 0.000 description 8
- 230000037322 slow-wave sleep Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002889 sympathetic effect Effects 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 230000003860 sleep quality Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010021033 Hypomenorrhoea Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 230000006742 locomotor activity Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000008454 sleep-wake cycle Effects 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010068932 Terminal insomnia Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 230000008035 nerve activity Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 244000134540 Polymnia sonchifolia Species 0.000 description 1
- 235000003406 Polymnia sonchifolia Nutrition 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L9/00—Puddings; Cream substitutes; Preparation or treatment thereof
- A23L9/10—Puddings; Dry powder puddings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04808121.0A EP1609375B1 (en) | 2004-01-14 | 2004-12-24 | Glycine-containing food and use thereof |
JP2005516994A JP4913410B2 (ja) | 2004-01-14 | 2004-12-24 | グリシンを含有する食品およびその用途 |
KR1020127023958A KR20120120423A (ko) | 2004-01-14 | 2004-12-24 | 글리신을 함유하는 식품 및 이의 용도 |
CN2004800116248A CN1780562B (zh) | 2004-01-14 | 2004-12-24 | 含甘氨酸食品及其应用 |
US11/165,200 US10561629B2 (en) | 2004-01-14 | 2005-06-24 | Food containing glycine and use thereof |
KR1020057020655A KR101214391B1 (ko) | 2004-01-14 | 2005-10-31 | 글리신을 함유하는 식품 및 이의 용도 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004007392 | 2004-01-14 | ||
JP2004-007392 | 2004-01-14 | ||
JP2004-158917 | 2004-05-28 | ||
JP2004158917 | 2004-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005067738A1 true WO2005067738A1 (ja) | 2005-07-28 |
Family
ID=34797738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/019771 WO2005067738A1 (ja) | 2004-01-14 | 2004-12-24 | グリシンを含有する食品およびその用途 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10561629B2 (ja) |
EP (1) | EP1609375B1 (ja) |
JP (5) | JP4913410B2 (ja) |
KR (2) | KR20120120423A (ja) |
CN (2) | CN102160650B (ja) |
WO (1) | WO2005067738A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006333872A (ja) * | 2004-01-14 | 2006-12-14 | Ajinomoto Co Inc | グリシンを含有する食品及びその用途 |
JP2008150352A (ja) * | 2006-12-15 | 2008-07-03 | Mg Seiyaku Kk | 睡眠改善剤組成物 |
JP5110314B2 (ja) * | 2006-04-28 | 2012-12-26 | ライオン株式会社 | 睡眠改善用組成物及び睡眠改善剤 |
WO2015053337A1 (ja) * | 2013-10-09 | 2015-04-16 | 味の素株式会社 | ヒスチジンを含有する食品およびその用途 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100488564C (zh) * | 2003-05-19 | 2009-05-20 | 味之素株式会社 | 打鼾或睡眠时呼吸障碍的预防、治疗剂 |
KR20120120423A (ko) * | 2004-01-14 | 2012-11-01 | 아지노모토 가부시키가이샤 | 글리신을 함유하는 식품 및 이의 용도 |
RU2566713C1 (ru) * | 2014-12-09 | 2015-10-27 | Николай Борисович Леонидов | Средство для лечения и профилактики нарушений сна |
EP3419528B1 (en) * | 2016-02-24 | 2023-06-07 | Incept, LLC | Enhanced flexibility neurovascular catheter |
KR102402639B1 (ko) | 2017-11-24 | 2022-05-26 | 삼성전자주식회사 | 전자 장치 및 그의 통신 방법 |
WO2020015744A1 (zh) * | 2018-07-19 | 2020-01-23 | 南京明德新药研发有限公司 | 氮杂吲哚衍生物及其作为FGFR和C-Met抑制剂的应用 |
JPWO2020080394A1 (ja) * | 2018-10-16 | 2021-09-09 | 日本ケミファ株式会社 | 睡眠の質の改善剤 |
JP2020172459A (ja) * | 2019-04-09 | 2020-10-22 | 国立大学法人 新潟大学 | アミロイドβタンパク質の凝集抑制剤及びアルツハイマー病の予防又は治療用医薬組成物 |
KR102329246B1 (ko) | 2019-05-09 | 2021-11-23 | 주식회사 엠에이치투 바이오케미칼 | 수면 유도 또는 수면 질 향상용 식품 또는 약학 조성물 |
JP6873291B1 (ja) | 2020-02-05 | 2021-05-19 | 雪印メグミルク株式会社 | 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料 |
KR20230005819A (ko) | 2020-04-14 | 2023-01-10 | 닛뽕 케미파 가부시키가이샤 | 수면의 질의 개선제 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04207161A (ja) * | 1990-11-30 | 1992-07-29 | Rohto Pharmaceut Co Ltd | サポニン及びアミノ酸含有組成物 |
JPH06505014A (ja) * | 1992-01-10 | 1994-06-09 | コミッサロバ,イリナ アレクセエフナ | 抗ストレス、ストレス予防性及び向神経性作用の医薬調製物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1052772A (en) * | 1974-11-14 | 1979-04-17 | Irving Goodman | Peptides for control of intestinal motility |
US4397866A (en) * | 1979-05-07 | 1983-08-09 | Massachusetts Institute Of Technology | Process for increasing glycine levels in the brain and spinal cord |
IT1212792B (it) * | 1983-11-30 | 1989-11-30 | Egidio Aldo Moja | Supplemento dietetico e alimento preconfezionato che lo contiene procedimento di preparazione e metodo di somministrazione |
US4758439A (en) * | 1984-06-11 | 1988-07-19 | Godfrey Science & Design, Inc. | Flavor of zinc supplements for oral use |
JPH0272853A (ja) * | 1988-01-07 | 1990-03-13 | Hiroe Ogawa | 食品用変質防止剤および食品の変質防止方法 |
US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
US4980168A (en) | 1989-10-13 | 1990-12-25 | Natrol, Inc. | Dietary supplement for children |
CN1078359A (zh) * | 1993-01-20 | 1993-11-17 | 中德联合研究院 | 一种益智健脑食品及其生产方法 |
US5480865A (en) * | 1994-02-25 | 1996-01-02 | Parkinson's Charitable Trust | Nutritional composition |
CN1110112A (zh) * | 1994-04-11 | 1995-10-18 | 贾增申 | 一种氨基酸固体饮料及其制备方法 |
US6461634B1 (en) * | 1999-08-20 | 2002-10-08 | Edward Marshall | Food-based delivery of HGH-stimulating and other nutritional supplements |
JP2001224334A (ja) * | 2000-02-16 | 2001-08-21 | Ajinomoto Co Inc | アミノ酸含有美容食品 |
KR100373501B1 (ko) * | 2000-09-20 | 2003-02-25 | 최병학 | 스트레스 예방 및 치료를 위한 항스트레스제 조성물 |
JP3550559B2 (ja) | 2001-10-18 | 2004-08-04 | アサヒ飲料株式会社 | グリシン含有飲料 |
DE10221403A1 (de) * | 2002-05-14 | 2003-12-04 | Kyberg Pharma Vertriebs Gmbh & | Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung |
RU2220712C1 (ru) * | 2002-07-18 | 2004-01-10 | ЗАО "НПО ПЦ Биофизика" | Средство и набор для нормализации функциональных нарушений, возникающих в предклимактерический и климактерический период |
CN100488564C (zh) * | 2003-05-19 | 2009-05-20 | 味之素株式会社 | 打鼾或睡眠时呼吸障碍的预防、治疗剂 |
AU2004241884B2 (en) * | 2003-05-22 | 2009-07-30 | N.V. Nutricia | A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
JP2006333872A (ja) * | 2004-01-14 | 2006-12-14 | Ajinomoto Co Inc | グリシンを含有する食品及びその用途 |
KR20120120423A (ko) * | 2004-01-14 | 2012-11-01 | 아지노모토 가부시키가이샤 | 글리신을 함유하는 식품 및 이의 용도 |
JP2006169221A (ja) * | 2004-12-13 | 2006-06-29 | Crescendo Corporation | おやすみサプリ |
-
2004
- 2004-12-24 KR KR1020127023958A patent/KR20120120423A/ko not_active Application Discontinuation
- 2004-12-24 CN CN2011100405432A patent/CN102160650B/zh active Active
- 2004-12-24 JP JP2005516994A patent/JP4913410B2/ja active Active
- 2004-12-24 EP EP04808121.0A patent/EP1609375B1/en active Active
- 2004-12-24 CN CN2004800116248A patent/CN1780562B/zh active Active
- 2004-12-24 WO PCT/JP2004/019771 patent/WO2005067738A1/ja not_active Application Discontinuation
-
2005
- 2005-06-24 US US11/165,200 patent/US10561629B2/en active Active
- 2005-10-31 KR KR1020057020655A patent/KR101214391B1/ko active IP Right Grant
-
2011
- 2011-02-01 JP JP2011020227A patent/JP5686615B2/ja active Active
-
2012
- 2012-06-21 JP JP2012140170A patent/JP2012211167A/ja not_active Withdrawn
-
2013
- 2013-01-09 JP JP2013002069A patent/JP5976552B2/ja active Active
-
2015
- 2015-06-24 JP JP2015126840A patent/JP6271472B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04207161A (ja) * | 1990-11-30 | 1992-07-29 | Rohto Pharmaceut Co Ltd | サポニン及びアミノ酸含有組成物 |
JPH06505014A (ja) * | 1992-01-10 | 1994-06-09 | コミッサロバ,イリナ アレクセエフナ | 抗ストレス、ストレス予防性及び向神経性作用の医薬調製物 |
Non-Patent Citations (2)
Title |
---|
See also references of EP1609375A4 * |
TERASAKI S. ET AL.: "Glycine no Riyo to sono Koka.", FOOD PROCESSING., vol. 27, no. 10, 1992, pages 11 - 14, XP008070333 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006333872A (ja) * | 2004-01-14 | 2006-12-14 | Ajinomoto Co Inc | グリシンを含有する食品及びその用途 |
JP5110314B2 (ja) * | 2006-04-28 | 2012-12-26 | ライオン株式会社 | 睡眠改善用組成物及び睡眠改善剤 |
JP2008150352A (ja) * | 2006-12-15 | 2008-07-03 | Mg Seiyaku Kk | 睡眠改善剤組成物 |
WO2015053337A1 (ja) * | 2013-10-09 | 2015-04-16 | 味の素株式会社 | ヒスチジンを含有する食品およびその用途 |
Also Published As
Publication number | Publication date |
---|---|
KR20060112593A (ko) | 2006-11-01 |
JPWO2005067738A1 (ja) | 2007-07-26 |
US20060003083A1 (en) | 2006-01-05 |
CN1780562B (zh) | 2011-04-13 |
JP5976552B2 (ja) | 2016-08-23 |
US10561629B2 (en) | 2020-02-18 |
CN102160650B (zh) | 2012-12-26 |
EP1609375B1 (en) | 2016-04-13 |
JP2015212282A (ja) | 2015-11-26 |
CN102160650A (zh) | 2011-08-24 |
KR101214391B1 (ko) | 2012-12-21 |
CN1780562A (zh) | 2006-05-31 |
JP4913410B2 (ja) | 2012-04-11 |
JP6271472B2 (ja) | 2018-01-31 |
EP1609375A4 (en) | 2006-08-30 |
JP5686615B2 (ja) | 2015-03-18 |
JP2013121961A (ja) | 2013-06-20 |
KR20120120423A (ko) | 2012-11-01 |
EP1609375A1 (en) | 2005-12-28 |
JP2011093933A (ja) | 2011-05-12 |
JP2012211167A (ja) | 2012-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6271472B2 (ja) | グリシンを含有する熟眠障害改善剤 | |
US20060127452A1 (en) | Method and composition for reducing cravings for a craved substance | |
WO2005097101A1 (ja) | 睡眠改善用組成物 | |
WO2013051728A1 (ja) | 睡眠の質改善剤 | |
KR100516341B1 (ko) | 흡연 욕구 억제 조성물 | |
US20170157075A1 (en) | Edible Compositions and Methods for Promoting Alpha Brain Waves | |
CN107624068B (zh) | 包含肉桂醛和锌的组合物及此类组合物的使用方法 | |
JP2006333872A (ja) | グリシンを含有する食品及びその用途 | |
CN106470691B (zh) | 包含肉桂醛和锌的组合物及此类组合物的使用方法 | |
JP3240345B2 (ja) | 経口催眠剤、催眠性飲食物及び催眠性餌料 | |
Hayter | Trace elements: implications for nursing | |
WO2015053337A1 (ja) | ヒスチジンを含有する食品およびその用途 | |
JP2005289948A (ja) | 睡眠改善用組成物 | |
JP6864964B2 (ja) | 経口睡眠改善剤 | |
JP6650852B2 (ja) | ドコサヘキサエン酸を含有する睡眠の質改善剤 | |
Dwivedi et al. | CAFEEINE: AN IMPORTANT COMPONENT OF OUR DAILY METABOLISM | |
JP7466748B1 (ja) | 肝機能の維持又は改善用組成物 | |
Gulya et al. | Aspartame and dizziness: preliminary results of a prospective, nonblinded, prevalence and attempted cross-over study | |
JP2006137746A (ja) | オレキシン誘導組成物 | |
JPH02174655A (ja) | 消化器系疾病治療効果を有する飲食品 | |
JP2015218119A (ja) | 睡眠改善剤及びそれを用いた飲食品 | |
Kushner | The Truth about Caffeine | |
Lacy | Hyperactivity/ADHD: New Solutions | |
WO2014163151A1 (ja) | 酵母培養物及び内服組成物 | |
US20130189391A1 (en) | Dry Powdered Comestibles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005516994 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004808121 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057020655 Country of ref document: KR Ref document number: 20048116248 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004808121 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057020655 Country of ref document: KR |